The Prevalence of Potential Drug-Drug Interactions in Patients with Heart Failure at Hospital Discharge

被引：0
|
作者：
Bernhard Straubhaar
Stephan Krähenbühl
Raymond G. Schlienger
机构：
[1] University of Basel,Department of Pharmaceutical Sciences, Institute of Clinical Pharmacy
[2] University Hospital of Basel,Division of Clinical Pharmacology and Toxicology
来源：
Drug Safety | 2006年 / 29卷
关键词：
Amiodarone; International Normalise Ratio; Heart Failure Patient; Carvedilol; Spironolactone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background/objective: Pharmacotherapy for heart failure is complex and, due to polypharmacy, is associated with a large risk of potential drug-drug interactions (DDIs). The objective of the present study was to assess the prevalence of potential DDIs in the medication of hospitalised heart failure patients and to evaluate their clinical relevance.
引用
收藏
页码：79 / 90
页数：11
相关论文
共 50 条
  • [31] The Prevalence and Severity of Potential Drug-Drug Interactions in Internal Medicine Ward at Soba Teaching Hospital
    Hamadouk, Riham M.
    Alshareif, Einass Mahmoud
    Hamad, Huda M.
    Yousef, Bashir A.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2023, 15 : 149 - 157
  • [32] POTENTIAL DRUG-DRUG INTERACTIONS IN OUTPATIENT PRESCRIPTIONS IN A GENERAL HOSPITAL
    Maria, A.
    Nicoletta, K.
    Pantelis, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 156 - 157
  • [33] Potential drug-drug interactions common in hospital prescriptions in Denmark
    Reactions Weekly, 2022, 1895 (1) : 9 - 9
  • [34] Potential drug-drug interactions in cardiology ward of a teaching hospital
    Ismail, Mohammad
    Iqbal, Zafar
    Khattak, Muhammad Bilal
    Khan, Muhammad Imran
    Javaid, Arshad
    Khan, Tahir Mehmood
    HEALTHMED, 2012, 6 (05): : 1618 - 1624
  • [35] Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments
    Fokter, Nina
    Mozina, Martin
    Brvar, Miran
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (3-4) : 81 - 88
  • [36] Potential Drug-Drug Interactions and Admissions Due to Drug-Drug Interactions in Patients Treated in Medical Departments
    Fokter, N.
    Mozina, M.
    Bone, M.
    Brvar, M.
    CLINICAL TOXICOLOGY, 2009, 47 (05) : 496 - 497
  • [37] Prevalence and clinical significance of potential drug-drug interactions among lung transplant patients
    Zhang, Jiali
    Ma, Danyi
    Chen, Meng
    Hu, Yanting
    Chen, Xveying
    Chen, Jingyu
    Huang, Man
    Dai, Haibin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [38] Polypharmacy in hematology and oncology patients and the resulting prevalence of potential drug-drug interactions (DDI)
    Metzke, B.
    Fink, G.
    Hieke, S.
    Jung, M.
    Hug, M. J.
    Engelhardt, M.
    ONKOLOGIE, 2012, 35 : 76 - 76
  • [39] Prevalence of potential drug-drug interactions in breast cancer patients and determination of their risk factors
    Bibi, Rashida
    Azhar, Saira
    Iqbal, Ayesha
    Jabeen, Hajera
    Kalsoom, Umm-e
    Iqbal, Muhammad M.
    Nazeer, Maria
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1616 - 1622
  • [40] Prevalence and significance of potential drug-drug interactions among cancer patients receiving chemotherapy
    Ismail, Mohammad
    Khan, Sehrash
    Khan, Fahadullah
    Noor, Sidra
    Sajid, Hira
    Yar, Shazia
    Rasheed, Irum
    BMC CANCER, 2020, 20 (01)
12345